July 28, 2016 5:46 PM ET

Biotechnology

Company Overview of ArQule Inc.

Executive Profile

Timothy C. Barabe

Independent Director and Chairman of Audit Committee, ArQule Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 9 different industries.

See Board Relationships
63$79,410

Background

Mr. Timothy C. Barabe, also known as Tim, served as the Chief Financial Officer and Executive Vice President and at Affymetrix Inc. from March 15, 2010 to June 28, 2013 and also served as its Principal Accounting Officer until June 28, 2013. Mr. Barabe served as the Chief Financial Officer and Principal Accounting Officer of Human Genome Sciences Inc., from July 10, 2006 to March 3, 2010 and from January 31, 2007 to March 3, 2010 respectively. He served as a Senior Vice ...

Corporate Headquarters

One Wall Street
Burlington, Massachusetts 01803

United States

Phone: 781-994-0300
Fax: --

Board Members Memberships

2001-Present
Independent Director and Chairman of Audit Committee
2014-Present
Independent Director, Chairman of Compensation Committee and Member of Audit Committee
2015-Present
Director and Member of Audit Committee
2015-Present
Director

Education

MBA
Loyola University Chicago
BBA
University Of Massachusetts

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$62,250
Total Calculated Compensation$79,410
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$919.8K
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$515.0K
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$882.2K
Raul R. Rodriguez Chief Executive Officer, President, Director and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$600.0K
Michael P. Bailey Chief Executive Officer, President and Director
AVEO Pharmaceuticals, Inc.
$510.0K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ArQule Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.